At a basic level, compounded semaglutide cannot be exactly the same as Ozempic, simply because its not made by Novo Nordisk, which is the only company that has received approval for medications that contain semaglutide: Ozempic, Wegovy, and Rybelsus
Then came a slew of new indications and off-label uses
It is essential to recognize the diverse needs of patients and provide them with effective solutions
The short answer: GLP-1 medications (semaglutide, tirzepatide, liraglutide, and others) can change normal hydration patterns through reduced thirst signaling, slowed gastric emptying, reduced fluid intake from suppressed appetite, and GI side effects that increase fluid loss
Optical coherence tomography Change in pRNFL thickness was not associated with the treatment group but with pRNFL thickness at baseline (M3: \(\beta\)= 0.32, 95% CI 0.41, 0.23
Heart rate effects should be evaluated in the context of overall tolerability and treatment goals